|
Agenda Item
ASR
Control 24-000015 |
||
|
MEETING
DATE: |
04/23/24 |
|
|
legal entity taking action: |
Board
of Supervisors |
|
|
board of supervisors district(s): |
2 |
|
|
SUBMITTING Agency/Department: |
Health
Care Agency (Approved) |
|
|
Department contact person(s): |
Jennifer
Sarin (714) 834-4099 |
|
|
|
Veronica
Kelley (714) 834-7024 |
|
Subject: Amendment
No. 2 for AlinIQ Inventory Management System
|
ceo CONCUR |
County Counsel Review |
Clerk of the
Board |
||||||||
|
Concur |
Approved Agreement to Form |
Discussion |
||||||||
|
|
|
3 Votes Board Majority |
||||||||
|
|
|
|
||||||||
|
Budgeted: Yes |
Current
Year Cost: $19,231 |
Annual
Cost: FY 2024-25 $76,923 |
||||||||
|
|
|
|
||||||||
|
Staffing
Impact:
|
No |
#
of Positions: |
Sole
Source: Yes |
|||||||
|
Current Fiscal Year Revenue: N/A
|
||||||||||
|
Prior Board Action: 3/22/2022 #27 |
||||||||||
RECOMMENDED
ACTION(S):
|
1. |
Approve Amendment No. 2 to the Contract
with Abbott Laboratories for AlinIQ Inventory Management System, effective
April 23, 2024, through June 30, 2027, to increase the Contract in an amount
not to exceed $250,000, for a revised total contract amount not to exceed
$617,100. |
|
2. |
Authorize the County Procurement Officer
or Deputized designee to execute Amendment No. 2 to the Contract with Abbott
Laboratories as referenced in the Recommended Action above. |
SUMMARY:
Approval of
Amendment No. 2 to the Contract with Abbott Laboratories for AlinIQ Inventory
Management System will allow the Orange County Public Health Laboratory to
improve inventory tracking and ordering.
BACKGROUND
INFORMATION:
On March 22, 2022,
your Honorable Board of Supervisors (Board) approved the Sole Source Contract
with Abbott Laboratories (Abbott) for AlinIQ Inventory Management System, to
purchase the AlinIQ Inventory Management System (IMS) and annual license.
AlinIQ IMS is the only inventory system that incorporates Abbott diagnostics
products by pre-generating tags for Abbott reagents and provides full
capabilities of an inventory management system built specifically for the lab
to ensure all accreditation requirements are met. AlinIQ IMS automates
inventory receiving and tracking of urine, blood, and swab specimens for
testing at the Orange County Public Health Laboratory (OCPHL) and Orange County
Water Testing Laboratory (OCWTL). AlinIQ IMS also maintains complete reagent
traceability records, including receipt dates and lot numbers.
All subsequent contract action is
represented in the table below:
|
Board
Date |
Contract/Amendment |
Action |
Term |
|
3/22/2022 |
Contract |
Board approved contract in an amount not
to exceed $350,000 |
April 1, 2022 – June 30, 2027 |
|
N/A |
Amendment No. 1 |
Amendment executed under Deputy
Purchasing Agent Authority to increase contract by $17, 100 for purchase of
additional hardware |
October 20, 2022 – June 30, 2027 |
HCA requests that the Board authorize the
County Procurement Officer or Deputized designee to execute Amendment No. 2 to
the Contract with Abbott Laboratories as referenced in the Recommended Actions.
The proposed
Amendment No. 2 to the Sole Source Contract with Abbott is to add the AlinIQ
Indexor, its consumables and maintenance for the OCPHL and OCWTL. AlinIQ
Indexor is a complementary product of Abbott’s AlinIQ IMS software solution
that integrates with the existing AlinIQ IMS. AlinIQ Indexor reduces the manual
paper process and streamlines and automates sample tracking, which simplifies
phlebotomy collection, digitally documents sample data during transport, and
improves visibility and processing. The OCPHL has Abbott Diagnostic and other
instruments in the virology section. Abbott’s administrative offices are
located out of state and Public Health Lab Services are provided to all
communities in Orange County. The Orange County Preference Policy is not
applicable to this contract amendment.
This Contract does not currently include
subcontractors or pass through to other providers. See Attachment C for
Contract Summary Form.
The Contractor's performance has been
confirmed as at least satisfactory. HCA has verified there are no concerns that
must be addressed with respect to Contractor's ownership/name, litigation
status or conflicts with County interests.
FINANCIAL IMPACT:
Appropriations for
this Amendment are included in Budget Control 042 FY 2023-24 Budget and will be
included in the budgeting process for future years.
The Contract
includes provisions allowing HCA to terminate the Contract, reduce the level of
services, and/or renegotiate the levels of services provided, as necessary.
This includes a notice that allows HCA adequate time to transition or terminate
services to clients, if necessary.
STAFFING IMPACT:
N/A
ATTACHMENT(S):
Attachment A – Amendment No. 2 to
Contract MA-042-22010731 with Abbott Laboratories
Attachment B – Redline to Attachment A
Attachment C – Contract Summary Form